Cat. No. | Product Name / Activity |
---|---|
2301 | T 0070907 |
Highly potent and selective covalent PPARγ antagonist | |
2302 | Sanguinarine chloride |
Inhibitor of protein phosphatase 2C (PP2C) | |
2303 | PNU 282987 |
Selective α7 nAChR agonist | |
2304 | Devazepide |
Selective, orally active CCK1 receptor antagonist | |
2305 | Tautomycetin |
Selective PP1 inhibitor | |
2306 | 15-deoxy-Δ-12,14-Prostaglandin J2 |
Endogenous PPARγ agonist | |
2307 | Leukotriene B4 |
BLT1/BLT2 receptor agonist and potent chemotactic factor | |
2308 | Tabimorelin hemifumarate |
Potent, orally active ghrelin receptor agonist | |
2309 | SR 142948 |
Highly potent NTS receptor antagonist | |
2310 | SR 49059 |
Selective, orally active vasopressin V1A receptor antagonist | |
2311 | L-168,049 |
Potent, orally active human glucagon receptor antagonist | |
2312 | DNQX disodium salt |
Selective non-NMDA iGluR antagonist; water-soluble salt of DNQX (Cat. No. 0189) | |
2313 | QX 314 chloride |
Na+ channel blocker | |
2314 | LOE 908 hydrochloride |
Broad spectrum cation channel blocker; neuroprotective | |
2315 | Immethridine dihydrobromide |
Potent H3 agonist, highly selective over H4 | |
2316 | AMG 9810 |
Potent and selective TRPV1 competitive antagonist | |
2318 | Pravastatin sodium salt |
HMG-CoA reductase inhibitor | |
2319 | CALP2 |
Cell-permeable calmodulin antagonist | |
2320 | TCS 184 |
Scrambled control peptide for use with TCS 183 (Cat. No. 2236) | |
2321 | CALP3 |
Cell-permeable calmodulin agonist | |
2322 | BTS 54-505 hydrochloride |
Potent 5-HT and NA reuptake inhibitor (SNRI); active metabolite of sibutramine (Cat. No. 2290) | |
2324 | Necrostatin-1 |
RIP1 kinase inhibitor; inhibits necroptosis | |
2329 | Ro 10-5824 dihydrochloride |
Selective D4 partial agonist | |
2330 | DMP 543 |
Potent, orally active ACh release enhancer | |
2332 | (+)-Igmesine hydrochloride |
Selective σ1 ligand; antidepressant | |
2333 | JNJ 16259685 |
Highly potent, mGlu1-selective non-competitive antagonist | |
2337 | Trequinsin hydrochloride |
Highly potent PDE3 inhibitor | |
2338 | MK 571 |
Potent CysLT1 (LTD4) inverse agonist. Also MRP1 inhibitor | |
2339 | WEB 2086 |
Potent PAF receptor antagonist | |
2341 | A 80426 mesylate |
High affinity α2 antagonist. Also 5-HT uptake inhibitor | |
2342 | 4-Methylhistamine dihydrochloride |
Selective, high affinity H4 agonist | |
2344 | CGH 2466 dihydrochloride |
A1, A2B and A3 antagonist and inhibitor of p38 MAPK and PDE4 | |
2345 | ZK 200775 |
Competitive non-NMDA iGluR antagonist | |
2347 | Salubrinal |
Selective inhibitor of eIF2α dephosphorylation | |
2348 | Gavestinel |
Potent and selective NMDA antagonist; acts at the glycine site | |
2349 | Dihydro-β-erythroidine hydrobromide |
α4β2, muscle type and Torpedo nAChR antagonist | |
2370 | Bombinakinin-GAP |
Bioactive, bradykinin-related peptide | |
2371 | Bombinakinin M |
Potent bradykinin agonist | |
2372 | ABT 702 hydrochloride |
Adenosine kinase inhibitor; orally active | |
2373 | T 0901317 |
Potent liver X receptor (LXR) agonist; also CAR inverse agonist | |
2382 | EMD 386088 hydrochloride |
Potent 5-HT6 agonist | |
2383 | Bryostatin 1 |
Protein kinase C activator | |
2385 | AMN 082 dihydrochloride |
Selective mGlu7 agonist | |
2386 | Fenobam |
Potent and selective mGlu5 negative allosteric modulator (NAM) | |
2387 | LY 320135 |
Selective CB1 inverse agonist | |
2390 | LY 456236 hydrochloride |
Selective mGlu1 antagonist | |
2391 | Astressin 2B |
Selective CRF2 antagonist | |
2392 | JTE 013 |
S1P2 receptor antagonist | |
2394 | SDZ NKT 343 |
Highly selective human NK1 antagonist | |
2396 | Glimepiride |
Kir6 (KATP) channel blocker | |
2397 | Eplerenone |
Selective mineralocorticoid receptor antagonist | |
2398 | SNAP 5089 |
Subtype-selective α1A antagonist |